nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PGR—uterine cancer	0.273	1	CbGaD
Fluticasone Propionate—NR3C2—Progesterone—uterine cancer	0.0845	0.21	CbGbCtD
Fluticasone Propionate—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0832	0.383	CrCrCtD
Fluticasone Propionate—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0824	0.205	CbGbCtD
Fluticasone Propionate—Fluorometholone—Medroxyprogesterone Acetate—uterine cancer	0.0692	0.319	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0647	0.298	CrCrCtD
Fluticasone Propionate—PLA2G4A—Epirubicin—uterine cancer	0.057	0.142	CbGbCtD
Fluticasone Propionate—PGR—Progesterone—uterine cancer	0.0546	0.136	CbGbCtD
Fluticasone Propionate—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0421	0.105	CbGbCtD
Fluticasone Propionate—NR3C1—Progesterone—uterine cancer	0.0279	0.0693	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0133	0.0331	CbGbCtD
Fluticasone Propionate—CYP3A7—Progesterone—uterine cancer	0.0133	0.0331	CbGbCtD
Fluticasone Propionate—CYP3A5—Progesterone—uterine cancer	0.00998	0.0248	CbGbCtD
Fluticasone Propionate—PGR—corpus luteum—uterine cancer	0.00597	0.174	CbGeAlD
Fluticasone Propionate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00587	0.0146	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—uterine cancer	0.00447	0.0111	CbGbCtD
Fluticasone Propionate—CYP3A4—Progesterone—uterine cancer	0.00389	0.00967	CbGbCtD
Fluticasone Propionate—SERPINA6—oviduct—uterine cancer	0.0027	0.0788	CbGeAlD
Fluticasone Propionate—PGR—oviduct—uterine cancer	0.00205	0.0598	CbGeAlD
Fluticasone Propionate—CYP3A4—Etoposide—uterine cancer	0.00174	0.00433	CbGbCtD
Fluticasone Propionate—PGR—artery—uterine cancer	0.00136	0.0396	CbGeAlD
Fluticasone Propionate—CYP3A4—Doxorubicin—uterine cancer	0.00119	0.00295	CbGbCtD
Fluticasone Propionate—PLA2G4A—myometrium—uterine cancer	0.000868	0.0253	CbGeAlD
Fluticasone Propionate—NR3C2—myometrium—uterine cancer	0.000706	0.0206	CbGeAlD
Fluticasone Propionate—PLA2G4A—uterine cervix—uterine cancer	0.000676	0.0197	CbGeAlD
Fluticasone Propionate—PLA2G4A—smooth muscle tissue—uterine cancer	0.000657	0.0191	CbGeAlD
Fluticasone Propionate—PGR—myometrium—uterine cancer	0.000656	0.0191	CbGeAlD
Fluticasone Propionate—PLA2G4A—decidua—uterine cancer	0.000644	0.0188	CbGeAlD
Fluticasone Propionate—PLA2G4A—renal system—uterine cancer	0.000632	0.0184	CbGeAlD
Fluticasone Propionate—SERPINA6—renal system—uterine cancer	0.000629	0.0184	CbGeAlD
Fluticasone Propionate—PLA2G4A—endometrium—uterine cancer	0.000611	0.0178	CbGeAlD
Fluticasone Propionate—PLA2G4A—mammalian vulva—uterine cancer	0.000591	0.0172	CbGeAlD
Fluticasone Propionate—NR3C2—uterine cervix—uterine cancer	0.000549	0.016	CbGeAlD
Fluticasone Propionate—NR3C2—smooth muscle tissue—uterine cancer	0.000534	0.0156	CbGeAlD
Fluticasone Propionate—PGR—epithelium—uterine cancer	0.000515	0.015	CbGeAlD
Fluticasone Propionate—NR3C2—renal system—uterine cancer	0.000514	0.015	CbGeAlD
Fluticasone Propionate—PGR—uterine cervix—uterine cancer	0.000511	0.0149	CbGeAlD
Fluticasone Propionate—PLA2G4A—female reproductive system—uterine cancer	0.000506	0.0148	CbGeAlD
Fluticasone Propionate—SERPINA6—female reproductive system—uterine cancer	0.000504	0.0147	CbGeAlD
Fluticasone Propionate—NR3C2—endometrium—uterine cancer	0.000497	0.0145	CbGeAlD
Fluticasone Propionate—PGR—smooth muscle tissue—uterine cancer	0.000496	0.0145	CbGeAlD
Fluticasone Propionate—PGR—decidua—uterine cancer	0.000487	0.0142	CbGeAlD
Fluticasone Propionate—NR3C2—mammalian vulva—uterine cancer	0.000481	0.014	CbGeAlD
Fluticasone Propionate—PGR—endometrium—uterine cancer	0.000462	0.0135	CbGeAlD
Fluticasone Propionate—PLA2G4A—female gonad—uterine cancer	0.000461	0.0134	CbGeAlD
Fluticasone Propionate—NR3C2—uterus—uterine cancer	0.000458	0.0134	CbGeAlD
Fluticasone Propionate—PLA2G4A—vagina—uterine cancer	0.000458	0.0134	CbGeAlD
Fluticasone Propionate—PGR—uterus—uterine cancer	0.000426	0.0124	CbGeAlD
Fluticasone Propionate—NR3C2—female reproductive system—uterine cancer	0.000412	0.012	CbGeAlD
Fluticasone Propionate—PGR—female reproductive system—uterine cancer	0.000383	0.0112	CbGeAlD
Fluticasone Propionate—NR3C1—myometrium—uterine cancer	0.000379	0.011	CbGeAlD
Fluticasone Propionate—NR3C2—female gonad—uterine cancer	0.000375	0.0109	CbGeAlD
Fluticasone Propionate—NR3C2—vagina—uterine cancer	0.000372	0.0109	CbGeAlD
Fluticasone Propionate—PGR—female gonad—uterine cancer	0.000348	0.0102	CbGeAlD
Fluticasone Propionate—PGR—vagina—uterine cancer	0.000346	0.0101	CbGeAlD
Fluticasone Propionate—NR3C1—epithelium—uterine cancer	0.000297	0.00867	CbGeAlD
Fluticasone Propionate—CYP3A5—uterine cervix—uterine cancer	0.000297	0.00866	CbGeAlD
Fluticasone Propionate—PLA2G4A—lymph node—uterine cancer	0.000296	0.00864	CbGeAlD
Fluticasone Propionate—NR3C1—uterine cervix—uterine cancer	0.000295	0.00859	CbGeAlD
Fluticasone Propionate—NR3C1—smooth muscle tissue—uterine cancer	0.000286	0.00835	CbGeAlD
Fluticasone Propionate—NR3C1—decidua—uterine cancer	0.000281	0.00819	CbGeAlD
Fluticasone Propionate—CYP3A5—renal system—uterine cancer	0.000278	0.0081	CbGeAlD
Fluticasone Propionate—NR3C1—renal system—uterine cancer	0.000276	0.00804	CbGeAlD
Fluticasone Propionate—NR3C1—endometrium—uterine cancer	0.000267	0.00777	CbGeAlD
Fluticasone Propionate—NR3C1—mammalian vulva—uterine cancer	0.000258	0.00752	CbGeAlD
Fluticasone Propionate—NR3C1—uterus—uterine cancer	0.000246	0.00716	CbGeAlD
Fluticasone Propionate—NR3C2—lymph node—uterine cancer	0.000241	0.00702	CbGeAlD
Fluticasone Propionate—Betamethasone—PGR—uterine cancer	0.000227	0.291	CrCbGaD
Fluticasone Propionate—PGR—lymph node—uterine cancer	0.000224	0.00653	CbGeAlD
Fluticasone Propionate—NR3C1—female reproductive system—uterine cancer	0.000221	0.00644	CbGeAlD
Fluticasone Propionate—CYP3A4—renal system—uterine cancer	0.000209	0.00608	CbGeAlD
Fluticasone Propionate—CYP3A5—female gonad—uterine cancer	0.000202	0.0059	CbGeAlD
Fluticasone Propionate—CYP3A5—vagina—uterine cancer	0.000201	0.00587	CbGeAlD
Fluticasone Propionate—NR3C1—female gonad—uterine cancer	0.000201	0.00586	CbGeAlD
Fluticasone Propionate—NR3C1—vagina—uterine cancer	0.0002	0.00582	CbGeAlD
Fluticasone Propionate—Dexamethasone—CYP11A1—uterine cancer	0.000175	0.224	CrCbGaD
Fluticasone Propionate—CYP3A4—female reproductive system—uterine cancer	0.000167	0.00487	CbGeAlD
Fluticasone Propionate—Betamethasone—CYP19A1—uterine cancer	0.000156	0.2	CrCbGaD
Fluticasone Propionate—Nervous system disorder—Progesterone—uterine cancer	0.000152	0.00261	CcSEcCtD
Fluticasone Propionate—Dysphonia—Epirubicin—uterine cancer	0.000151	0.0026	CcSEcCtD
Fluticasone Propionate—Tachycardia—Progesterone—uterine cancer	0.000151	0.0026	CcSEcCtD
Fluticasone Propionate—Skin disorder—Progesterone—uterine cancer	0.00015	0.00258	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Doxorubicin—uterine cancer	0.00015	0.00258	CcSEcCtD
Fluticasone Propionate—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000146	0.00251	CcSEcCtD
Fluticasone Propionate—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000146	0.00251	CcSEcCtD
Fluticasone Propionate—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000146	0.0025	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000145	0.0025	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Etoposide—uterine cancer	0.000145	0.00249	CcSEcCtD
Fluticasone Propionate—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.00248	CcSEcCtD
Fluticasone Propionate—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000143	0.00246	CcSEcCtD
Fluticasone Propionate—Ageusia—Doxorubicin—uterine cancer	0.000142	0.00244	CcSEcCtD
Fluticasone Propionate—Stinging—Doxorubicin—uterine cancer	0.000142	0.00244	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000141	0.00242	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00014	0.00241	CcSEcCtD
Fluticasone Propionate—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00014	0.00241	CcSEcCtD
Fluticasone Propionate—Dysphonia—Doxorubicin—uterine cancer	0.00014	0.0024	CcSEcCtD
Fluticasone Propionate—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00239	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Progesterone—uterine cancer	0.000138	0.00237	CcSEcCtD
Fluticasone Propionate—Viral infection—Epirubicin—uterine cancer	0.000138	0.00237	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00236	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Etoposide—uterine cancer	0.000137	0.00235	CcSEcCtD
Fluticasone Propionate—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00235	CcSEcCtD
Fluticasone Propionate—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.00234	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Epirubicin—uterine cancer	0.000135	0.00232	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Epirubicin—uterine cancer	0.000135	0.00232	CcSEcCtD
Fluticasone Propionate—Erythema—Dactinomycin—uterine cancer	0.000134	0.0023	CcSEcCtD
Fluticasone Propionate—Dexamethasone—PGR—uterine cancer	0.000132	0.169	CrCbGaD
Fluticasone Propionate—Pain—Progesterone—uterine cancer	0.000132	0.00227	CcSEcCtD
Fluticasone Propionate—NR3C1—lymph node—uterine cancer	0.000129	0.00377	CbGeAlD
Fluticasone Propionate—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000128	0.0022	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Progesterone—uterine cancer	0.000127	0.00219	CcSEcCtD
Fluticasone Propionate—Viral infection—Doxorubicin—uterine cancer	0.000127	0.00219	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Progesterone—uterine cancer	0.000126	0.00217	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000125	0.00215	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Doxorubicin—uterine cancer	0.000125	0.00215	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Doxorubicin—uterine cancer	0.000125	0.00215	CcSEcCtD
Fluticasone Propionate—Pneumonia—Etoposide—uterine cancer	0.000125	0.00215	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Dactinomycin—uterine cancer	0.000124	0.00214	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Etoposide—uterine cancer	0.000124	0.00213	CcSEcCtD
Fluticasone Propionate—Infestation—Etoposide—uterine cancer	0.000124	0.00213	CcSEcCtD
Fluticasone Propionate—Urticaria—Progesterone—uterine cancer	0.000123	0.00211	CcSEcCtD
Fluticasone Propionate—Dermatitis contact—Epirubicin—uterine cancer	0.000123	0.00211	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Progesterone—uterine cancer	0.000122	0.0021	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Progesterone—uterine cancer	0.000122	0.0021	CcSEcCtD
Fluticasone Propionate—Malaise—Dactinomycin—uterine cancer	0.000121	0.00208	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Epirubicin—uterine cancer	0.000121	0.00208	CcSEcCtD
Fluticasone Propionate—Candida infection—Epirubicin—uterine cancer	0.000119	0.00204	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000115	0.00199	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000115	0.00197	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Progesterone—uterine cancer	0.000114	0.00196	CcSEcCtD
Fluticasone Propionate—Dermatitis contact—Doxorubicin—uterine cancer	0.000114	0.00195	CcSEcCtD
Fluticasone Propionate—Discomfort—Dactinomycin—uterine cancer	0.000113	0.00194	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Doxorubicin—uterine cancer	0.000112	0.00192	CcSEcCtD
Fluticasone Propionate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.00191	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Etoposide—uterine cancer	0.000111	0.0019	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.0019	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.0019	CcSEcCtD
Fluticasone Propionate—Candida infection—Doxorubicin—uterine cancer	0.00011	0.00189	CcSEcCtD
Fluticasone Propionate—Pruritus—Progesterone—uterine cancer	0.000109	0.00188	CcSEcCtD
Fluticasone Propionate—Oedema—Dactinomycin—uterine cancer	0.000109	0.00188	CcSEcCtD
Fluticasone Propionate—Infection—Dactinomycin—uterine cancer	0.000109	0.00187	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Progesterone—uterine cancer	0.000106	0.00182	CcSEcCtD
Fluticasone Propionate—Eye disorder—Etoposide—uterine cancer	0.000104	0.00179	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Epirubicin—uterine cancer	0.000104	0.00178	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Etoposide—uterine cancer	0.000103	0.00178	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000103	0.00178	CcSEcCtD
Fluticasone Propionate—Dizziness—Progesterone—uterine cancer	0.000102	0.00176	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Etoposide—uterine cancer	0.000101	0.00173	CcSEcCtD
Fluticasone Propionate—Eczema—Epirubicin—uterine cancer	0.0001	0.00173	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Etoposide—uterine cancer	0.0001	0.00173	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Dactinomycin—uterine cancer	9.96e-05	0.00171	CcSEcCtD
Fluticasone Propionate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	9.91e-05	0.0017	CcSEcCtD
Fluticasone Propionate—Vomiting—Progesterone—uterine cancer	9.83e-05	0.00169	CcSEcCtD
Fluticasone Propionate—Rash—Progesterone—uterine cancer	9.75e-05	0.00168	CcSEcCtD
Fluticasone Propionate—Dermatitis—Progesterone—uterine cancer	9.74e-05	0.00167	CcSEcCtD
Fluticasone Propionate—Headache—Progesterone—uterine cancer	9.69e-05	0.00167	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Doxorubicin—uterine cancer	9.6e-05	0.00165	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	9.59e-05	0.00165	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Epirubicin—uterine cancer	9.44e-05	0.00162	CcSEcCtD
Fluticasone Propionate—Pain—Dactinomycin—uterine cancer	9.35e-05	0.00161	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Epirubicin—uterine cancer	9.32e-05	0.0016	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Etoposide—uterine cancer	9.32e-05	0.0016	CcSEcCtD
Fluticasone Propionate—Eczema—Doxorubicin—uterine cancer	9.29e-05	0.0016	CcSEcCtD
Fluticasone Propionate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	9.27e-05	0.00159	CcSEcCtD
Fluticasone Propionate—Nausea—Progesterone—uterine cancer	9.19e-05	0.00158	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP19A1—uterine cancer	9.07e-05	0.116	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Dactinomycin—uterine cancer	9.01e-05	0.00155	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Etoposide—uterine cancer	8.99e-05	0.00155	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dactinomycin—uterine cancer	8.94e-05	0.00154	CcSEcCtD
Fluticasone Propionate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	8.91e-05	0.00153	CcSEcCtD
Fluticasone Propionate—Rash—Medroxyprogesterone Acetate—uterine cancer	8.84e-05	0.00152	CcSEcCtD
Fluticasone Propionate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	8.83e-05	0.00152	CcSEcCtD
Fluticasone Propionate—Headache—Medroxyprogesterone Acetate—uterine cancer	8.78e-05	0.00151	CcSEcCtD
Fluticasone Propionate—Malaise—Etoposide—uterine cancer	8.74e-05	0.0015	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Doxorubicin—uterine cancer	8.74e-05	0.0015	CcSEcCtD
Fluticasone Propionate—Face oedema—Epirubicin—uterine cancer	8.71e-05	0.0015	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dactinomycin—uterine cancer	8.64e-05	0.00149	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dactinomycin—uterine cancer	8.64e-05	0.00149	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Doxorubicin—uterine cancer	8.63e-05	0.00148	CcSEcCtD
Fluticasone Propionate—Cough—Etoposide—uterine cancer	8.46e-05	0.00145	CcSEcCtD
Fluticasone Propionate—Hypertension—Etoposide—uterine cancer	8.37e-05	0.00144	CcSEcCtD
Fluticasone Propionate—Nausea—Medroxyprogesterone Acetate—uterine cancer	8.32e-05	0.00143	CcSEcCtD
Fluticasone Propionate—Chest pain—Etoposide—uterine cancer	8.25e-05	0.00142	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	8.2e-05	0.00141	CcSEcCtD
Fluticasone Propionate—Discomfort—Etoposide—uterine cancer	8.15e-05	0.0014	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Epirubicin—uterine cancer	8.07e-05	0.00139	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—uterine cancer	8.06e-05	0.00139	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Dactinomycin—uterine cancer	8.05e-05	0.00138	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Etoposide—uterine cancer	7.91e-05	0.00136	CcSEcCtD
Fluticasone Propionate—Infection—Etoposide—uterine cancer	7.86e-05	0.00135	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Epirubicin—uterine cancer	7.85e-05	0.00135	CcSEcCtD
Fluticasone Propionate—Asthma—Epirubicin—uterine cancer	7.8e-05	0.00134	CcSEcCtD
Fluticasone Propionate—Tachycardia—Etoposide—uterine cancer	7.72e-05	0.00133	CcSEcCtD
Fluticasone Propionate—Skin disorder—Etoposide—uterine cancer	7.68e-05	0.00132	CcSEcCtD
Fluticasone Propionate—Bronchitis—Epirubicin—uterine cancer	7.5e-05	0.00129	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dactinomycin—uterine cancer	7.48e-05	0.00129	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—uterine cancer	7.47e-05	0.00128	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—uterine cancer	7.26e-05	0.00125	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Epirubicin—uterine cancer	7.25e-05	0.00125	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—uterine cancer	7.22e-05	0.00124	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Etoposide—uterine cancer	7.05e-05	0.00121	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Epirubicin—uterine cancer	7.03e-05	0.00121	CcSEcCtD
Fluticasone Propionate—Pneumonia—Epirubicin—uterine cancer	6.99e-05	0.0012	CcSEcCtD
Fluticasone Propionate—Infestation—Epirubicin—uterine cancer	6.95e-05	0.0012	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Epirubicin—uterine cancer	6.95e-05	0.0012	CcSEcCtD
Fluticasone Propionate—Vomiting—Dactinomycin—uterine cancer	6.95e-05	0.00119	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—uterine cancer	6.94e-05	0.00119	CcSEcCtD
Fluticasone Propionate—Rash—Dactinomycin—uterine cancer	6.89e-05	0.00118	CcSEcCtD
Fluticasone Propionate—Pain—Etoposide—uterine cancer	6.77e-05	0.00116	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Epirubicin—uterine cancer	6.76e-05	0.00116	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—uterine cancer	6.71e-05	0.00115	CcSEcCtD
Fluticasone Propionate—Epistaxis—Epirubicin—uterine cancer	6.56e-05	0.00113	CcSEcCtD
Fluticasone Propionate—Sinusitis—Epirubicin—uterine cancer	6.52e-05	0.00112	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Etoposide—uterine cancer	6.52e-05	0.00112	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—uterine cancer	6.51e-05	0.00112	CcSEcCtD
Fluticasone Propionate—Nausea—Dactinomycin—uterine cancer	6.49e-05	0.00112	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—uterine cancer	6.47e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Etoposide—uterine cancer	6.47e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—uterine cancer	6.43e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—uterine cancer	6.43e-05	0.00111	CcSEcCtD
Fluticasone Propionate—Urticaria—Etoposide—uterine cancer	6.28e-05	0.00108	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—uterine cancer	6.25e-05	0.00108	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—uterine cancer	6.25e-05	0.00108	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—uterine cancer	6.25e-05	0.00108	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—uterine cancer	6.21e-05	0.00107	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—uterine cancer	6.2e-05	0.00107	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—uterine cancer	6.13e-05	0.00105	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—uterine cancer	6.07e-05	0.00104	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—uterine cancer	6.04e-05	0.00104	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—uterine cancer	5.83e-05	0.001	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—uterine cancer	5.83e-05	0.001	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—uterine cancer	5.79e-05	0.000996	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—uterine cancer	5.75e-05	0.000988	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—uterine cancer	5.73e-05	0.000986	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—uterine cancer	5.68e-05	0.000976	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—uterine cancer	5.64e-05	0.000969	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—uterine cancer	5.63e-05	0.000967	CcSEcCtD
Fluticasone Propionate—Pruritus—Etoposide—uterine cancer	5.6e-05	0.000962	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Epirubicin—uterine cancer	5.58e-05	0.000959	CcSEcCtD
Fluticasone Propionate—Mental disorder—Epirubicin—uterine cancer	5.47e-05	0.00094	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—uterine cancer	5.43e-05	0.000934	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—uterine cancer	5.43e-05	0.000934	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Etoposide—uterine cancer	5.41e-05	0.000931	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—uterine cancer	5.4e-05	0.000928	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—uterine cancer	5.36e-05	0.000922	CcSEcCtD
Fluticasone Propionate—Dizziness—Etoposide—uterine cancer	5.23e-05	0.000899	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Epirubicin—uterine cancer	5.22e-05	0.000898	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—uterine cancer	5.22e-05	0.000897	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—uterine cancer	5.21e-05	0.000895	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—uterine cancer	5.16e-05	0.000887	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—uterine cancer	5.12e-05	0.00088	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—uterine cancer	5.06e-05	0.00087	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—uterine cancer	5.04e-05	0.000867	CcSEcCtD
Fluticasone Propionate—Vomiting—Etoposide—uterine cancer	5.03e-05	0.000865	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—uterine cancer	5.03e-05	0.000864	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—uterine cancer	5.03e-05	0.000864	CcSEcCtD
Fluticasone Propionate—Agitation—Epirubicin—uterine cancer	4.99e-05	0.000859	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—uterine cancer	4.99e-05	0.000858	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—uterine cancer	4.98e-05	0.000857	CcSEcCtD
Fluticasone Propionate—Headache—Etoposide—uterine cancer	4.96e-05	0.000852	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—uterine cancer	4.9e-05	0.000842	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—uterine cancer	4.83e-05	0.000831	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—uterine cancer	4.8e-05	0.000826	CcSEcCtD
Fluticasone Propionate—Cough—Epirubicin—uterine cancer	4.74e-05	0.000815	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—uterine cancer	4.74e-05	0.000815	CcSEcCtD
Fluticasone Propionate—Nausea—Etoposide—uterine cancer	4.7e-05	0.000808	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—uterine cancer	4.69e-05	0.000807	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—uterine cancer	4.66e-05	0.000802	CcSEcCtD
Fluticasone Propionate—Arthralgia—Epirubicin—uterine cancer	4.63e-05	0.000795	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—uterine cancer	4.63e-05	0.000795	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—uterine cancer	4.62e-05	0.000794	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—uterine cancer	4.61e-05	0.000793	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	4.59e-05	0.00079	CcSEcCtD
Fluticasone Propionate—Discomfort—Epirubicin—uterine cancer	4.57e-05	0.000786	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—uterine cancer	4.53e-05	0.00078	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—uterine cancer	4.52e-05	0.000778	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—uterine cancer	4.44e-05	0.000764	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—uterine cancer	4.43e-05	0.000762	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—uterine cancer	4.43e-05	0.000762	CcSEcCtD
Fluticasone Propionate—Infection—Epirubicin—uterine cancer	4.41e-05	0.000757	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—uterine cancer	4.39e-05	0.000754	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—uterine cancer	4.35e-05	0.000748	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—uterine cancer	4.34e-05	0.000746	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—uterine cancer	4.33e-05	0.000744	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—uterine cancer	4.31e-05	0.000741	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—uterine cancer	4.28e-05	0.000736	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—uterine cancer	4.28e-05	0.000736	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—uterine cancer	4.27e-05	0.000733	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.25e-05	0.000731	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—uterine cancer	4.23e-05	0.000727	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—uterine cancer	4.19e-05	0.00072	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—uterine cancer	4.1e-05	0.000705	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—uterine cancer	4.1e-05	0.000705	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—uterine cancer	4.08e-05	0.000701	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.04e-05	0.000695	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—uterine cancer	4.02e-05	0.000692	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—uterine cancer	4e-05	0.000689	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—uterine cancer	3.99e-05	0.000685	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Epirubicin—uterine cancer	3.95e-05	0.00068	CcSEcCtD
Fluticasone Propionate—Pain—Epirubicin—uterine cancer	3.79e-05	0.000652	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.74e-05	0.000643	CcSEcCtD
Fluticasone Propionate—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	3.68e-05	0.00266	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Doxorubicin—uterine cancer	3.66e-05	0.000629	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—uterine cancer	3.65e-05	0.000628	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—ERBB2—uterine cancer	3.63e-05	0.00262	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—uterine cancer	3.63e-05	0.000623	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CDKN1B—uterine cancer	3.61e-05	0.00261	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Epirubicin—uterine cancer	3.52e-05	0.000606	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—uterine cancer	3.51e-05	0.000603	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.51e-05	0.00253	CbGpPWpGaD
Fluticasone Propionate—Abdominal pain—Epirubicin—uterine cancer	3.51e-05	0.000603	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—uterine cancer	3.51e-05	0.000603	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	3.49e-05	0.00252	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—CTNNB1—uterine cancer	3.49e-05	0.00252	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—uterine cancer	3.43e-05	0.00247	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CTNNB1—uterine cancer	3.41e-05	0.00246	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—uterine cancer	3.38e-05	0.000581	CcSEcCtD
Fluticasone Propionate—PGR—Generic Transcription Pathway—ESR2—uterine cancer	3.37e-05	0.00243	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.36e-05	0.00243	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—CDKN1B—uterine cancer	3.36e-05	0.00242	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—ESR1—uterine cancer	3.36e-05	0.00242	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—uterine cancer	3.36e-05	0.000577	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Endothelins—HRAS—uterine cancer	3.34e-05	0.00241	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	3.33e-05	0.0024	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	3.28e-05	0.00237	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Epirubicin—uterine cancer	3.27e-05	0.000562	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—uterine cancer	3.26e-05	0.00056	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	3.26e-05	0.00235	CbGpPWpGaD
Fluticasone Propionate—Body temperature increased—Doxorubicin—uterine cancer	3.24e-05	0.000558	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—uterine cancer	3.24e-05	0.000558	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	3.17e-05	0.00229	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Epirubicin—uterine cancer	3.14e-05	0.000539	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—PTEN—uterine cancer	3.09e-05	0.00223	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	3.09e-05	0.00223	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Epirubicin—uterine cancer	3.03e-05	0.000522	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—PGR—uterine cancer	3.03e-05	0.00218	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—uterine cancer	3.02e-05	0.00218	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—uterine cancer	3.02e-05	0.00052	CcSEcCtD
Fluticasone Propionate—NR3C1—Gene Expression—PHF1—uterine cancer	3.01e-05	0.00217	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.98e-05	0.00215	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PTEN—uterine cancer	2.96e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IRF1—uterine cancer	2.95e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—AKT1—uterine cancer	2.95e-05	0.00213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NDUFB11—uterine cancer	2.94e-05	0.00212	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SRD5A2—uterine cancer	2.94e-05	0.00212	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.94e-05	0.00212	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Epirubicin—uterine cancer	2.93e-05	0.000504	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—uterine cancer	2.9e-05	0.000499	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—EZH2—uterine cancer	2.88e-05	0.00208	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	2.87e-05	0.00207	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.86e-05	0.00206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—AKT1—uterine cancer	2.84e-05	0.00205	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	2.82e-05	0.00204	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Epirubicin—uterine cancer	2.82e-05	0.000485	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—uterine cancer	2.81e-05	0.000483	CcSEcCtD
Fluticasone Propionate—Rash—Epirubicin—uterine cancer	2.8e-05	0.000481	CcSEcCtD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	2.79e-05	0.00202	CbGpPWpGaD
Fluticasone Propionate—Dermatitis—Epirubicin—uterine cancer	2.79e-05	0.00048	CcSEcCtD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	2.78e-05	0.002	CbGpPWpGaD
Fluticasone Propionate—Headache—Epirubicin—uterine cancer	2.78e-05	0.000478	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—NRAS—uterine cancer	2.76e-05	0.00199	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	2.76e-05	0.00199	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	2.75e-05	0.00198	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PTEN—uterine cancer	2.73e-05	0.00197	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	2.72e-05	0.00196	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Doxorubicin—uterine cancer	2.71e-05	0.000467	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.7e-05	0.00195	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—ESR2—uterine cancer	2.67e-05	0.00192	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—NRAS—uterine cancer	2.64e-05	0.0019	CbGpPWpGaD
Fluticasone Propionate—Nausea—Epirubicin—uterine cancer	2.63e-05	0.000453	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—uterine cancer	2.61e-05	0.000449	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—uterine cancer	2.59e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—uterine cancer	2.58e-05	0.000444	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—uterine cancer	2.57e-05	0.000442	CcSEcCtD
Fluticasone Propionate—NR3C1—Gene Expression—CHD4—uterine cancer	2.56e-05	0.00184	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	2.51e-05	0.00181	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.47e-05	0.00178	CbGpPWpGaD
Fluticasone Propionate—Nausea—Doxorubicin—uterine cancer	2.44e-05	0.000419	CcSEcCtD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.42e-05	0.00174	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—KRAS—uterine cancer	2.38e-05	0.00171	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKR1B10—uterine cancer	2.34e-05	0.00169	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.29e-05	0.00165	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	2.27e-05	0.00164	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—KRAS—uterine cancer	2.27e-05	0.00164	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	2.21e-05	0.0016	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	2.18e-05	0.00157	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—CDKN2B—uterine cancer	2.17e-05	0.00157	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.16e-05	0.00156	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SUZ12—uterine cancer	2.14e-05	0.00154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKR1B1—uterine cancer	2.13e-05	0.00154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—STAR—uterine cancer	2.13e-05	0.00154	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.11e-05	0.00152	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.11e-05	0.00152	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.1e-05	0.00152	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—uterine cancer	2.09e-05	0.0015	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—CTNNB1—uterine cancer	2.08e-05	0.0015	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NDUFB11—uterine cancer	2.05e-05	0.00148	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SRD5A2—uterine cancer	2.05e-05	0.00148	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—ESR1—uterine cancer	2.05e-05	0.00148	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—HRAS—uterine cancer	2.02e-05	0.00146	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.01e-05	0.00145	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	2e-05	0.00144	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—SMAD3—uterine cancer	1.98e-05	0.00143	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	1.95e-05	0.00141	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.95e-05	0.00141	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RNF43—uterine cancer	1.94e-05	0.0014	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—HRAS—uterine cancer	1.93e-05	0.00139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PIK3CA—uterine cancer	1.93e-05	0.00139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKR1B10—uterine cancer	1.91e-05	0.00138	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.9e-05	0.00137	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.85e-05	0.00134	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.8e-05	0.0013	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—AKT1—uterine cancer	1.78e-05	0.00129	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—INHBA—uterine cancer	1.78e-05	0.00128	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—EZH2—uterine cancer	1.75e-05	0.00126	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.74e-05	0.00126	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.72e-05	0.00124	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.71e-05	0.00123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.69e-05	0.00122	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	1.69e-05	0.00122	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	1.67e-05	0.00121	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—POLD1—uterine cancer	1.67e-05	0.0012	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ESR2—uterine cancer	1.62e-05	0.00117	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.62e-05	0.00117	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—ESR1—uterine cancer	1.62e-05	0.00117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.62e-05	0.00117	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKR1C1—uterine cancer	1.6e-05	0.00115	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	1.59e-05	0.00114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RNF43—uterine cancer	1.59e-05	0.00114	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.58e-05	0.00114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKR1C1—uterine cancer	1.56e-05	0.00113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.49e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—STAR—uterine cancer	1.48e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.48e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.48e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.48e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INHBA—uterine cancer	1.45e-05	0.00105	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	1.45e-05	0.00105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.44e-05	0.00104	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—RRM2—uterine cancer	1.39e-05	0.001	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—DCN—uterine cancer	1.35e-05	0.000975	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—CDKN2B—uterine cancer	1.32e-05	0.000954	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.32e-05	0.000954	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKR1C1—uterine cancer	1.31e-05	0.000942	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.28e-05	0.000925	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP11A1—uterine cancer	1.27e-05	0.000918	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.27e-05	0.000913	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKR1C3—uterine cancer	1.23e-05	0.000888	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.21e-05	0.000875	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SMAD3—uterine cancer	1.21e-05	0.000871	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKR1C3—uterine cancer	1.2e-05	0.000867	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	1.18e-05	0.000853	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—POLD1—uterine cancer	1.16e-05	0.000839	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—YWHAE—uterine cancer	1.14e-05	0.000825	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FBXW7—uterine cancer	1.1e-05	0.000791	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.09e-05	0.000785	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.08e-05	0.000779	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.07e-05	0.000773	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—STAR—uterine cancer	1.07e-05	0.000773	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PGR—uterine cancer	1.07e-05	0.000769	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—EZH2—uterine cancer	1.01e-05	0.000731	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKR1C3—uterine cancer	1.01e-05	0.000725	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—ESR1—uterine cancer	9.85e-06	0.000711	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PGR—uterine cancer	9.8e-06	0.000707	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—RRM2—uterine cancer	9.7e-06	0.0007	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STK11—uterine cancer	9.59e-06	0.000692	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—DCN—uterine cancer	9.42e-06	0.000679	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR2—uterine cancer	9.39e-06	0.000677	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—STK11—uterine cancer	9.37e-06	0.000676	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP19A1—uterine cancer	9.37e-06	0.000676	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—YWHAE—uterine cancer	9.35e-06	0.000674	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—EP300—uterine cancer	9.21e-06	0.000664	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SOCS3—uterine cancer	8.98e-06	0.000648	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FBXW7—uterine cancer	8.96e-06	0.000646	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP11A1—uterine cancer	8.87e-06	0.00064	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.79e-06	0.000634	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—uterine cancer	8.72e-06	0.000629	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NRAS—uterine cancer	8.62e-06	0.000622	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN2B—uterine cancer	8.6e-06	0.00062	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—POLD1—uterine cancer	8.41e-06	0.000607	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.39e-06	0.000605	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKR1C3—uterine cancer	8.38e-06	0.000604	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1R—uterine cancer	8.35e-06	0.000602	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1C1—uterine cancer	7.87e-06	0.000568	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SMAD3—uterine cancer	7.85e-06	0.000566	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STK11—uterine cancer	7.83e-06	0.000565	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CCL2—uterine cancer	7.8e-06	0.000562	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CDKN2B—uterine cancer	7.64e-06	0.000551	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGFR2—uterine cancer	7.49e-06	0.00054	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—uterine cancer	7.42e-06	0.000535	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SOCS3—uterine cancer	7.33e-06	0.000529	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—uterine cancer	7.04e-06	0.000508	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—uterine cancer	7.02e-06	0.000507	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—RRM2—uterine cancer	7.01e-06	0.000506	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SMAD3—uterine cancer	6.98e-06	0.000503	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SRD5A2—uterine cancer	6.89e-06	0.000497	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NDUFB11—uterine cancer	6.89e-06	0.000497	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1R—uterine cancer	6.82e-06	0.000492	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—uterine cancer	6.81e-06	0.000492	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—DCN—uterine cancer	6.81e-06	0.000491	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—uterine cancer	6.59e-06	0.000476	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—STK11—uterine cancer	6.53e-06	0.000471	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP19A1—uterine cancer	6.53e-06	0.000471	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP11A1—uterine cancer	6.41e-06	0.000463	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SMAD3—uterine cancer	6.41e-06	0.000462	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ESR1—uterine cancer	6.4e-06	0.000462	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—uterine cancer	6.3e-06	0.000455	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.2e-06	0.000447	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—uterine cancer	6.16e-06	0.000445	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGFR2—uterine cancer	6.11e-06	0.000441	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKR1C3—uterine cancer	6.06e-06	0.000437	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—uterine cancer	5.83e-06	0.000421	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR1—uterine cancer	5.69e-06	0.000411	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL2—uterine cancer	5.64e-06	0.000407	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—uterine cancer	5.57e-06	0.000402	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ESR1—uterine cancer	5.23e-06	0.000377	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.98e-06	0.000359	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—STAR—uterine cancer	4.98e-06	0.000359	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—NRAS—uterine cancer	4.95e-06	0.000357	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—uterine cancer	4.91e-06	0.000354	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP19A1—uterine cancer	4.72e-06	0.00034	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—STK11—uterine cancer	4.72e-06	0.00034	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—uterine cancer	4.7e-06	0.000339	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL2—uterine cancer	4.61e-06	0.000332	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—uterine cancer	4.46e-06	0.000322	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—uterine cancer	4.35e-06	0.000314	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—uterine cancer	4.26e-06	0.000307	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—uterine cancer	4.11e-06	0.000297	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—uterine cancer	4.01e-06	0.000289	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—uterine cancer	3.92e-06	0.000282	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—POLD1—uterine cancer	3.91e-06	0.000282	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—uterine cancer	3.91e-06	0.000282	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—uterine cancer	3.84e-06	0.000277	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EP300—uterine cancer	3.82e-06	0.000276	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—EP300—uterine cancer	3.73e-06	0.000269	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.66e-06	0.000264	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—uterine cancer	3.64e-06	0.000263	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—uterine cancer	3.62e-06	0.000261	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—uterine cancer	3.62e-06	0.000261	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRAS—uterine cancer	3.58e-06	0.000258	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—uterine cancer	3.56e-06	0.000257	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—uterine cancer	3.55e-06	0.000256	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—uterine cancer	3.55e-06	0.000256	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—uterine cancer	3.36e-06	0.000242	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—uterine cancer	3.27e-06	0.000236	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RRM2—uterine cancer	3.26e-06	0.000235	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—uterine cancer	3.19e-06	0.00023	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—DCN—uterine cancer	3.17e-06	0.000228	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EP300—uterine cancer	3.12e-06	0.000225	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—uterine cancer	3.08e-06	0.000222	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.98e-06	0.000215	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—uterine cancer	2.96e-06	0.000213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRAS—uterine cancer	2.92e-06	0.000211	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—uterine cancer	2.83e-06	0.000204	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.82e-06	0.000203	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—uterine cancer	2.76e-06	0.000199	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—uterine cancer	2.74e-06	0.000197	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—uterine cancer	2.73e-06	0.000197	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—uterine cancer	2.62e-06	0.000189	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—EP300—uterine cancer	2.6e-06	0.000188	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—uterine cancer	2.51e-06	0.000181	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—uterine cancer	2.31e-06	0.000167	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—uterine cancer	2.31e-06	0.000167	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—uterine cancer	2.26e-06	0.000163	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—uterine cancer	2.23e-06	0.000161	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—STK11—uterine cancer	2.19e-06	0.000158	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.19e-06	0.000158	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—uterine cancer	2.14e-06	0.000154	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—uterine cancer	2.05e-06	0.000148	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—uterine cancer	1.97e-06	0.000142	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.93e-06	0.000139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—uterine cancer	1.89e-06	0.000136	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—EP300—uterine cancer	1.88e-06	0.000136	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—uterine cancer	1.65e-06	0.000119	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—uterine cancer	1.57e-06	0.000113	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.39e-06	0.0001	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—uterine cancer	1.14e-06	8.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—uterine cancer	9.17e-07	6.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—EP300—uterine cancer	8.75e-07	6.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—uterine cancer	6.47e-07	4.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—uterine cancer	5.29e-07	3.81e-05	CbGpPWpGaD
